IMNM

15.6905.54%
MR

Max Rosett

Chief Financial Officer

Mr. Max Rosett serves as Chief Financial Officer of Immunome, Inc. since May 09, 2024 and had been its Interim Chief Financial Officer since January 2024 until May 09, 2024. and serves as its Principal Financial and Accounting Officer. He served as Executive Vice President of Operations and Principal Financial Officer of Immunome, Inc. from December 2023. He was Senior Vice President of Operations of Immunome, Inc. from October 2023, until December 2023. He joined Morphimmune as in January 2022 and served as its Acting Chief Operating Officer from March 2022 until October 2023. Mr. Rosett also served as Principal at Research Bridge Partners, a life science investment firm, from March 2021 until October 2023. He was previously Director of Data Science at Research Bridge Partners from February 2018 to February 2021. He has also worked as an engineer at Google and he started his career at the Boston Consulting Group, where he served clients in the pharmaceutical industry. Mr. Rosett earned a M.S. in Computer Science from Georgia Institute of Technology and a B.A. in Mathematics from Yale University.

Positions